External resources PMC: A three-phase framework for combining GLP-1 receptor agonists with intermittent fasting , National Library of Medicine STEP-1 trial: Once-weekly semaglutide in adults with overweight or obesity , New England Journal of Medicine SURMOUNT-1 trial: Tirzepatide once weekly for the treatment of obesity , New England Journal of Medicine Weight management information and clinical resources , National Institute of Diabetes and Digestive and Kidney Diseases PubMed research database , National Library of Medicine For researchers serious about optimizing their GLP-1 protocols, SeekPeptides provides comprehensive protocol guides, dosing calculators, and a community of thousands navigating these exact questions
Obesity, obstructive sleep apnea, knee osteoarthritis pain, chronic low back pain, MASLD, type 2 diabetes, cardiovascular outcomes, and heart failure with preserved ejection fraction are all in the program
Peptide therapy has recently gone mainstream thanks to popular peptides like semaglutide (Ozempic) and tirzepatide (Mounjaro)
People with absorption disorders, older adults, vegans, vegetarians, and those with certain stomach or intestinal conditions may be at higher risk
